Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 16/12/2016, Revision: 11, Status: Authorised | Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 16/12/2016, Revision: 11, Status: Authorised | | Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections;Uterine Cervical Dysplasia;Immunization, Date of authorisation: 20/09/2007, Rev | Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections;Uterine Cervical Dysplasia;Immunization, Date of authorisation: 20/09/2007, Revision: 38, Status: Authorised | | Van (te veel) medicatie kan je suïcidaal depressief worden | Diana: Ik heb duizenden keren geschreeuwd dat ik dood wilde en daarbij aangegeven dat dit door te voor mij te hoge dosering kwam Het bericht Van (te veel) medicatie kan je suïcidaal depressief worden verscheen eerst op PsychoseNet. | | Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2022, Status: Authorised | Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2022, Status: Authorised | | |